Navigation Links
Mirati Therapeutics Reports Second Quarter 2014 Financial Results and Provides Business Update
Date:8/8/2014

m is using a proven blueprint for developing targeted oncology medicines to advance and maximize the value of its pipeline of drug candidates, including MGCD265 and MGCD516, which are orally bioavailable, multi-targeted kinase inhibitors with distinct target profiles, and mocetinostat, an orally bio-available, spectrum-selective histone deacetylase inhibitor. More information is available at www.mirati.com.

Forward Looking Statements
Certain statements contained in this news release, other than statements of fact that are independently verifiable at the date hereof, may constitute forward-looking information and forward-looking statements (collectively "forward-looking statements" within the meaning of applicable securities laws). Such statements, based as they are on the current expectations of management of Mirati and upon what management believes to be reasonable assumptions based on information currently available to it, inherently involve numerous risks and uncertainties, known and unknown, many of which are beyond Mirati's control. Such statements can usually be identified by the use of words such as "may", "would", "believe", "intend", "plan", "anticipate", "estimate" and other similar terminology, or state that certain actions, events or results "may" or "would" be taken, occur or be achieved. Forward-looking statements in this release include, but are not limited to, statements regarding the timing of initiating and reporting data from clinical trials, the potential for MGCD265 to show signals of activity in Met and Axl pathways and the potential for accelerated approval pathways.

Whether actual results and developments will conform with our expectations and predictions is subject to a number of risks, assumptions and uncertainties, many of which are beyond our control, and the effects of which can be difficult to predict. These risks include those inherent in drug development, whether Mirati will
'/>"/>

SOURCE Mirati Therapeutics, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Mirati Presents Clinical Response Results of Mocetinostat in Combination with Azacitidine as a Treatment for MDS
2. Updated Presentation Time: Mirati Therapeutics to Present at the 25th Annual Piper Jaffray Healthcare Conference
3. Mirati Therapeutics to Present at the 25th Annual Piper Jaffray Healthcare Conference
4. Mirati Therapeutics Reports Third Quarter 2013 Financial Results
5. Mirati Therapeutics Prices Public Offering Of Common Stock
6. Mast Therapeutics To Present At The Canaccord Genuity 34th Annual Growth Conference On August 14th
7. Orexigen Therapeutics Reports Corporate and Financial Results for the Second Quarter Ended June 30, 2014
8. PTC Therapeutics Reports Second Quarter Financial Results and Provides Corporate Update
9. Pivotal Therapeutics To Explore Potential Commercial Partnership Opportunities in China
10. Relmada Therapeutics, Inc. Completes Name Change and Announces New Ticker
11. PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... , April 24, 2015  Lannett Company, Inc. (NYSE: ... and increased its five-year revolving credit facility to $120 ... accordion feature that will allow the company to increase ... $30.0 million, subject to securing additional commitments from existing ... the credit facility remains December 18, 2018.   ...
(Date:4/24/2015)... Spain , April 24, 2015  Elekta has ... Monaco® treatment planning system , enabling European clinics ... supports major treatment techniques including advanced 3D planning, IMRT, ... system. Monaco ... as well improved workflow efficiency. Advancements in 3D planning ...
(Date:4/23/2015)... April 23, 2015  Edwards Lifesciences Corporation (NYSE: EW ... valves and hemodynamic monitoring, today reported net income for ... $1.12 per diluted share.  Net income for the same ... per diluted share, and non-GAAP net income was $82.1 ... sales for the quarter ended March 31, 2015 increased 13.0 ...
Breaking Medicine Technology:Lannett Expands Revolving Credit Facility To $120 Million 2Elekta CE marks for Monaco v5.10 treatment planning system 2Edwards Lifesciences Reports First Quarter Results 2Edwards Lifesciences Reports First Quarter Results 3Edwards Lifesciences Reports First Quarter Results 4Edwards Lifesciences Reports First Quarter Results 5Edwards Lifesciences Reports First Quarter Results 6Edwards Lifesciences Reports First Quarter Results 7Edwards Lifesciences Reports First Quarter Results 8Edwards Lifesciences Reports First Quarter Results 9Edwards Lifesciences Reports First Quarter Results 10Edwards Lifesciences Reports First Quarter Results 11Edwards Lifesciences Reports First Quarter Results 12Edwards Lifesciences Reports First Quarter Results 13Edwards Lifesciences Reports First Quarter Results 14Edwards Lifesciences Reports First Quarter Results 15Edwards Lifesciences Reports First Quarter Results 16
(Date:4/25/2015)... Phoenix, AZ (PRWEB) April 25, 2015 Parker ... plumbing, heating, and cooling, has spiked in Arizona alongside the ... on an additional forty employees for April to help account ... , “Hiring forty employees in April is something we are ... the economy,” said Paul Kelly, president at Parker and Sons. ...
(Date:4/25/2015)... For thirteen years, the Twin Cities DI Day ... in the nation! This year, on May 5th, 2015, Secura ... take DI Day on the road by supporting the first ... RHU, DIA, CLTC, Chief Executive Officer at Secura Consultants and ... change by stating, "The first Twin Cities DI Day was ...
(Date:4/24/2015)... 24, 2015 As the nation recognizes ... unique sacrifices of these young men and women, the ... Veterans and their Families” presents a special training session ... to gain a better understanding of the effect of ... For those – civilian and military – who provide ...
(Date:4/24/2015)... New York (PRWEB) April 24, 2015 ... to move forward in the federal multidistrict litigation ... Carolina. According to court documents, the parties involved ... on April 16th detailing, among other things, preparation ... notes that counsel for both plaintiffs and defendants ...
(Date:4/24/2015)... Lowcostcarinsuranceprice.com has released a new blog ... insurance for senior citizens . , Senior citizens ... not mean that they cannot find affordable coverage. By ... find the right coverage for their cars at the ... http://lowcostcarinsuranceprice.com/ provides free leads from various agencies ...
Breaking Medicine News(10 mins):Health News:Parker and Sons Plans to Expand in 2015 2Health News:Secura Consultants Takes DI Day On The Road 2Health News:Coalition Presents Resiliency Training to Raise Awareness during Month of the Military Child (#MOTMC2015) 2Health News:Federal Lipitor Lawsuits Progress, as New Status Report Details Preparation for Upcoming Bellwether Trials 2Health News:Federal Lipitor Lawsuits Progress, as New Status Report Details Preparation for Upcoming Bellwether Trials 3Health News:Low Cost Auto Insurance Quotes for Senior Citizens 2
... standard chemo boosted survival, study found , FRIDAY, ... myeloma live longer when thalidomide is added to standard ... finding could be the first real treatment advance for ... , Standard chemotherapy for elderly patients involves two drugs, ...
... Presentation to highlight milestones including phase III development of ... What: Horizon Therapeutics, Inc. is pleased to announce that ... M.D., Ph.D., chief executive officer, will ... including its recent completion of Series C financing, and ...
... Lilly and Company,announced today that as a part ... Administration (FDA), the company has updated the Zyprexa(R),(olanzapine) ... This new labeling information is available at ... reflect recently completed pooled analyses of Lilly,s,clinical trial ...
... SAN FRANCISCO, Calif., Oct. 5 Anesiva,Inc. (Nasdaq: ... company,s,chief executive officer, will present at the Biotechnology Industry,Organization,s ... am PDT in San Francisco. To access the ... http://www.anesiva.com and go to the Investors page, ...
... NGOs, Sports, Academic, and Business Leaders Issue a, Call to ... ... Disabilities, ... organizations (NGOs), sports,academic and business representing 60 countries gathered today ...
... Everything Is A Victory, Especially When People, Control Own Lives; But ... Weiner Seeks Prosecution Of Everyone In Her Entourage Including Coach; ... Other Athletes And Children Beware, ... 2000 Olympic medals, or the Olympics should force her to,return them," ...
Cached Medicine News:Health News:Thalidomide Improves Outcomes for Older Myeloma Patients 2Health News:Horizon Therapeutics, Inc. Scheduled to Present at Upcoming BioPartnering Europe Meeting 2Health News:Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels 2Health News:Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels 3Health News:Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels 4Health News:Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels 5Health News:Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels 6Health News:Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels 7Health News:Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels 8Health News:Global Leaders Converge for Special Olympics Global Policy Summit 2Health News:Global Leaders Converge for Special Olympics Global Policy Summit 3Health News:Global Leaders Converge for Special Olympics Global Policy Summit 4Health News:Marian Jones Should Return Olympic Medals, Says Ex-White House Drug Spokesman Bob Weiner 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: